← All candidates
49 insider filings on record.
49 filings on record.
TNYATenaya Therapeutics, Inc.
NasdaqCM · Healthcare · $147.48M
$0.6577
-1.98% · Sep 16
49 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 35 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$147.48M
Float
211.7M
94% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
110.5
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
44 more transactions on Pro →Context
Wall St
$3.20 avg target
+386.5% vs today · 5 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.09 act−$0.02
Q1 '26−$0.09 act−$0.00
Q4 '25−$0.12 act+$0.00
Q3 '25−$0.12 act+$0.03
Coverage
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301MarketBeat · 08-18Treasury yields rise as investors raise bets on Fed rate hike: AlphaCheckYahoo Finance · 6d agoExploring 3 High Growth Tech Stocks in US MarketSimply Wall St. · 06-15Exploring High Growth Tech Stocks In The US MarketSimply Wall St. · 06-11
The file stays open
49 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice